نمایش پرونده ساده آیتم

dc.contributor.authorshafiei, Mohammad zahir
dc.date.accessioned2020-02-12T08:31:32Z
dc.date.available2020-02-12T08:31:32Z
dc.date.issued2016en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/61461
dc.description.abstractThe purpose of this study was to evaluate the efficacy of digestive-resistant starch in correcting and altering gastrointestinal flora in end-stage renal disease patients under chronic hemodialysis.Materials and Methods: In this double-blind clinical trial, 20 hemodialysis patients were selected from patients referred to Tabriz University of Medical Sciences' clinics. These patients were randomly divided into control and treatment groups. Patients in the treatment group received daily 25 grams of amylose-rich starch for 2 months and were finally compared for quantitative microbial comunity analysis.Results: The control group showed only statistically significant changes in Prevotella and Faecalibacterium genus. There was a statistically significant increase in the two genotypes in this group. There was a statistically significant difference in the Bacteroides genotype in the intervention group in the reduction of coloniesen_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, School of Medicineen_US
dc.subjectindigestible Starchen_US
dc.subjectChronic Kidney diseaseen_US
dc.subjectBacteroidesen_US
dc.titleThe effects of diet enriched with indigestible/fermentable complex carbohydrates on intestinal microbiota of chronic hemodialysis patientsen_US
dc.typeThesisen_US
dc.contributor.supervisorTayebi Khosroshahi, Hamid
dc.identifier.docno609338en_US
dc.identifier.callno9338en_US
dc.description.disciplineMedicineen_US
dc.description.degreeMD.Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم